Results 91 to 100 of about 1,604 (142)

Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL. [PDF]

open access: yesBlood Adv
Mauro MJ   +24 more
europepmc   +1 more source

Development and impact of virtual reality-based training for the radial forearm free flap: A multi-center prospective feasibility study. [PDF]

open access: yesJPRAS Open
Mahmood A   +25 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy